CH505 TF chTrimer
- Generic Name
- CH505 TF chTrimer
Safety and Immunogenicity of Stabilized CH505 TF chTrimer Vaccination in Adults Living With HIV-1 on Suppressive Antiretroviral Therapy
- Conditions
- HIV-1
- Interventions
- Other: Sodium Chloride for InjectionBiological: 3M-052-AF
- First Posted Date
- 2024-11-08
- Last Posted Date
- 2025-03-25
- Target Recruit Count
- 30
- Registration Number
- NCT06680479
- Locations
- ๐บ๐ธ
University of California, Los Angeles CARE Center CRS, Los Angeles, California, United States
๐บ๐ธUCSD Antiviral Research Center CRS, San Diego, California, United States
๐บ๐ธUniversity of California, San Francisco HIV/AIDS CRS, San Francisco, California, United States
A Clinical Trial in Adult Participants Without HIV and in Overall Good Health to Evaluate the Safety and Immunogenicity of CD4BS CH505M5 Pr-NP1 Followed by CH505 TF chTrimer Boost Both Adjuvanted With Either Lipid Nanoparticles (LNPs) or 3M-052-AF + Alum
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2025-03-26
- Target Recruit Count
- 42
- Registration Number
- NCT06267872
- Locations
- ๐บ๐ธ
Alabama CRS (Site ID: 31788), Birmingham, Alabama, United States
๐บ๐ธThe Ponce de Leon Center CRS (Site ID: 5802), Atlanta, Georgia, United States
๐บ๐ธVanderbilt Vaccine (VV) CRS (Site ID: 30352), Nashville, Tennessee, United States
Evaluating the Safety and Immunogenicity of Stabilized CH505 TF chTrimer in Healthy, HIV-uninfected Adult Participants.
- Conditions
- HIV Infections
- Interventions
- First Posted Date
- 2021-06-07
- Last Posted Date
- 2024-10-02
- Target Recruit Count
- 52
- Registration Number
- NCT04915768
- Locations
- ๐บ๐ธ
Vanderbilt Vaccine (VV) CRS, Nashville, Tennessee, United States
๐บ๐ธThe Hope Clinic of the Emory Vaccine Center CRS, Decatur, Georgia, United States
๐บ๐ธBrigham and Women's CRS, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.